DIA 2005 is selected to unveil the most extensive, flexible and intuitive
Electronic Publishing system for the Life Sciences market
Philadelphia, PA, USA-London, UK - June 27, 2005 - Thomson
Scientific today announced that Liquent is poised to release its next generation
electronic publishing solution, Liquent InSight® Publisher.
The solution is set to have a major positive impact on pharmaceutical and biotechnology
companies' publishing abilities as they migrate to the eCTD.
Following months of collaboration with the Liquent Customer Advisory Board,
and in response to the exacting demands of the life sciences market and its
regulatory authorities, InSight Publisher has been developed to appeal
to existing Liquent CoreDossier® and Liquent EZsubs®
customers, as well as to entice new customers to the fold. Delegates at the
forthcoming DIA 2005 event in Washington, DC will be among the first to preview
this new electronic publishing system that is positioned to change the landscape
of life sciences publishing processes.
InSight Publisher, which will be generally available in August 2005,
delivers unrivalled publishing functionality coupled with an intuitive user
interface that will boost the Liquent position as the leader in regulatory solutions
for the life sciences sector. In its initial release, InSight Publisher
will provide complete eCTD submission publishing and lifecycle management. In
subsequent releases, InSight Publisher will expand to also enable creation
of paper CTD submissions from an original eCTD as well as complete paper submission
publishing capabilities.
“We have just completed our annual Liquent 2005 Regulatory Submissions
Trends survey and the decision to launch InSight Publisher couldn’t
be timelier,” said Jim Nichols, Vice President of Product Strategy and
Marketing, Liquent. “More than three-quarters of survey respondents stated
their plan to migrate to the eCTD, one third of which plan to do so in the next
ten to eighteen months. InSight Publisher is perfectly positioned to
respond to this planned migration by offering the most modern, comprehensive
and intuitive solution to handle these publishing demands.”
As part of Liquent’s ongoing commitment to the hundreds of life sciences
companies that rely on its technologies to control the production and publishing
of their electronic documents, Liquent has announced that it is offering InSight
Publisher free of any license fee to all existing CoreDossier
and EZsubs clients as part of their maintenance agreements. (See customer
news release dated 27.06.05 for qualifying details). This decision is fuelled
by Liquent’s focus on customer service and commitment to providing its
customers with a roadmap of electronic publishing solutions that manage their
publishing needs both now and in the future.
“The Liquent approach is in line with our expectations and planning,”
said Gerhard Schlueter, Head of Global Regulatory Operations, Bayer HealthCare’s
Pharmaceutical Division. “This will enable us to have a smooth transition
from EZsubs to InSight Publisher and will support the further
eCTD implementation.”
InSight Publisher is also offered as an integrated module of Liquent’s
regulatory product management suite, InSight Manager, thereby boosting
its position as the most comprehensive product management lifecycle solution
for the life sciences market. InSight Manager Release 2.0 will also
be launched at the DIA 2005 event and it boasts extended capabilities including
- registration planning & tracking; product detail management, submission
planning & tracking and registered document analysis.
InSight Publisher and InSight Manager 2.0 are available for
demonstration at the DIA 41st Annual Meeting in Washington, DC on June 26th
through 30th. Visit the Liquent booth, number 251.
For more information on the Liquent Regulatory Affairs Trends survey, its findings
and how to secure a copy, please contact info@liquent.com.
About Liquent regulatory solutions
Liquent regulatory solutions provide software, information products,
and related services for the life sciences industry. These solutions and services
help ensure clients meet the strict standards of regulatory authorities across
the world helping them achieve quality, accuracy, and data integrity to deliver
regulatory reports and submissions reliably and on time. In addition to technology
and services, the Liquent IDRAC database service provides the most comprehensive
intelligence on the drug and biologics regulatory environment in 38 of the largest
markets in the world.
As a result, 48 of the top 50 global life sciences companies rely on Liquent
regulatory solutions to stay current with the latest intelligence and to provide
the technology and services to compress the regulatory submissions and approval
process, improving speed to market, cost control, and productivity, all of which
contribute to ensuring patients’ and physicians’ timely access to
new drugs. Over the last decade, more than 5,000 regulatory submissions have
been produced using Liquent world-class products and expert services. For more
information please visit, www.liquent.com.
